Targeted Therapy of Colorectal Cancer Subtypes
In this book, a group of researchers shares their expertise on the identification and characterization of genetic colorectal cancer subtypes. They describe solid pathobiological knowledge on the distinct sporadic tumour subtypes, including the mutations found in oncogenes and tumour suppressor genes...
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Cham :
Springer International Publishing
2018.
|
| Colección: | Springer eBooks.
Advances in Experimental Medicine and Biology ; 1110. |
| Acceso en línea: | Conectar con la versión electrónica |
| Ver en Universidad de Navarra: | https://innopac.unav.es/record=b38298028*spi |
Tabla de Contenidos:
- Preface
- Colorectal Cancer Subtypes- the current portrait
- Targeting colon cancers with mutated BRAF and microsatellite instability
- Targeting KRAS mutant CMS3 subtype by metabolic inhibitors
- Targeting the PI3K Signalling as a Therapeutic Strategy in Colorectal Cancer
- Targeting PTEN in colorectal cancers
- Wnt signalling-targeted therapy in the CMS2 tumour subtype: a new paradigm in CRC treatment?- Impact of the microenvironment on tumour budding in colorectal cancer
- Anti-EGFR Therapy to treat metastatic colorectal cancer: not for all
- miRNAs as modulators of EGFR therapy in colorectal cancer
- Index.
